시장보고서
상품코드
1338878

심장 마커 검사 시장 점유율, 규모, 동향, 산업 분석 보고서 : 제품 유형별, 최종사용자별, 지역별, 부문별 예측(2023-2032년)

Cardiac Marker Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents and Kits and Instruments); By Biomarker Type; By End-User; By Region; Segment Forecast, 2023-2032

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 116 Pages | 배송안내 : 1-2일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 연구에 따르면, 세계 심장 마커 검사 시장 규모는 2032년까지 97억 3,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

전 세계적으로 응급실(ED)에서 심혈관 질환 환자 수가 급증하고, POCT와 같은 여러 심장 바이오마커 검사에 대한 수요 증가와 채택이 세계 시장 성장을 촉진하는 주요 요인으로 작용하고 있습니다. 또한, 신규 업체들은 수익 극대화를 위해 지속적으로 검사 시장에 진입하고 있으며, 기존 업체들은 연구개발(R&D)에 투자하여 포트폴리오를 개발하고 확장하는 데 주력하고 있습니다. 예를 들어, 2023년 1월 Cipla는 당뇨병, 감염, 갑상선 기능, 염증, 대사 마커 검사를 제공하는 CE IVD 승인 현장 검사 장비인 'Cippoint'라는 새로운 검사 장비를 발표했습니다.

또한, 심장 마커의 최근 발전은 상용 기기에서 심근 트로포닌, 나트륨 이뇨 펩타이드와 같은 새로운 기술과 한 번의 분석으로 여러 분자 표적을 통해 다중화를 가능하게 하여 특이성과 신뢰성을 향상시킨 Point-of-Care 면역 분석에 이르기까지 다양합니다. 있습니다. 밀레니얼 세대의 건강에 해로운 음식 섭취 증가로 협심증 환자가 증가하고 있으며, 이러한 환자군의 급증하는 수요에 대응하기 위해 심장 바이오마커의 채택이 빠르게 증가하고 있습니다.

암을 비롯한 다양한 질병의 유병률이 크게 증가함에 따라 각국 정부는 의료 시스템 개발 및 첨단 심장 마커 검사 장비에 대한 접근성을 높이기 위해 시간과 자금을 집중 투자하고 있습니다. 예를 들어, 미국심장학회(American College of Cardiology)의 새로운 연구에 따르면, 연구진은 ApoB 검사가 LDL 콜레스테롤 수치가 정상이 아니더라도 심혈관 위험이 높은 환자를 식별하는 데 도움이 될 수 있다는 사실을 발견했습니다.

심장 마커 검사 시장 보고서 하이라이트

심장 바이오마커 검사 도입 증가로 시약 및 키트 분야가 2022년 세계 시장 점유율의 대부분을 차지할 것

Troponin I 및 T 부문은 주로 급성 심근경색 진단을 위한 이러한 기기에 대한 수요 증가로 인해 2022년에 큰 시장 수익 점유율을 차지했습니다.

주요 의료 서비스 제공업체들의 사용 확대로 인해 POC(Point-of-Care) 시설 분야는 조사 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다.

북미 지역이 2022년 세계 시장을 장악할 것으로 예상되는데, 이는 헬스케어 인프라에 대한 높은 지출과 미국, 캐나다 등의 국가에서 선진화된 심장 바이오마커가 빠르게 채택되고 있기 때문입니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 심장 마커 검사 시장 인사이트

  • 심장 마커 검사 시장 - 바이오마커 종류 현황
  • 심장 마커 검사 시장 역학
    • 성장 촉진요인과 기회
      • 심혈관질환 발생률 상승
      • 첨단 기술 진보
    • 성장 억제요인과 과제
      • 샘플 수집과 보관에 관한 기술적 문제
  • PESTEL 분석
  • 심장 마커 검사 시장 바이오마커 종류 동향
  • 밸류체인 분석
  • COVID-19 감염증의 영향 분석

제5장 세계의 심장 마커 검사 시장, 제품별

  • 주요 조사 결과
  • 서론
  • 시약과 키트
  • 장비

제6장 세계의 심장 마커 검사 시장, 용도별

  • 주요 조사 결과
  • 서론
  • 임상 검사 시설
  • POC(Point of Care) 검사 시설
  • 학술기관

제7장 세계의 심장 마커 검사 시장, 바이오마커 유형별

  • 주요 조사 결과
  • 서론
  • 트로포닌 I와 T
  • 크레아틴 키나아제-MB(CK-MB)
  • 나트륨 이뇨 펩타이드
  • 미오글로빈
  • 고감도 C반응성 단백질
  • 기타 심장 바이오마커

제8장 세계의 심장 마커 검사 시장, 지역별

  • 주요 조사 결과
  • 서론
    • 심장 마커 검사 시장 평가, 지역별, 2019-2032년
  • 심장 마커 검사 시장 - 북미
    • 북미 : 심장 마커 검사 시장, 제품별, 2019-2032년
    • 북미 : 심장 마커 검사 시장, 바이오마커 유형별, 2019-2032년
    • 북미 : 심장 마커 검사 시장, 용도별, 2019-2032년
    • 심장 마커 검사 시장 - 미국
    • 심장 마커 검사 시장 - 캐나다
  • 심장 마커 검사 시장 - 유럽
    • 유럽 : 심장 마커 검사 시장, 제품별, 2019-2032년
    • 유럽 : 심장 마커 검사 시장, 바이오마커 유형별, 2019-2032년
    • 유럽 : 심장 마커 검사 시장, 용도별, 2019-2032년
    • 심장 마커 검사 시장 - 영국
    • 심장 마커 검사 시장 - 프랑스
    • 심장 마커 검사 시장 - 독일
    • 심장 마커 검사 시장 - 이탈리아
    • 심장 마커 검사 시장 - 스페인
    • 심장 마커 검사 시장 - 네델란드
    • 심장 마커 검사 시장 - 러시아
  • 심장 마커 검사 시장 - 아시아태평양
    • 아시아태평양 : 심장 마커 검사 시장, 제품별, 2019-2032년
    • 아시아태평양 : 심장 마커 검사 시장, 바이오마커 유형별, 2019-2032년
    • 아시아태평양 : 심장 마커 검사 시장, 용도별, 2019-2032년
    • 심장 마커 검사 시장 - 중국
    • 심장 마커 검사 시장 - 인도
    • 심장 마커 검사 시장 - 말레이시아
    • 심장 마커 검사 시장 - 일본
    • 심장 마커 검사 시장 - 인도네시아
    • 심장 마커 검사 시장 - 한국
  • 심장 마커 검사 시장 - 중동 및 아프리카
    • 중동 및 아프리카 : 심장 마커 검사 시장, 제품별, 2019-2032년
    • 중동 및 아프리카 : 심장 마커 검사 시장, 바이오마커 유형별, 2019-2032년
    • 중동 및 아프리카 : 심장 마커 검사 시장, 용도별, 2019-2032년
    • 심장 마커 검사 시장 - 사우디아라비아
    • 심장 마커 검사 시장 - 아랍에미리트
    • 심장 마커 검사 시장 - 이스라엘
    • 심장 마커 검사 시장 - 남아프리카
  • 심장 마커 검사 시장 - 라틴아메리카
    • 라틴아메리카 : 심장 마커 검사 시장, 제품별, 2019-2032년
    • 라틴아메리카 : 심장 마커 검사 시장, 바이오마커 유형별, 2019-2032년
    • 라틴아메리카 : 심장 마커 검사 시장, 용도별, 2019-2032년
    • 심장 마커 검사 시장 - 멕시코
    • 심장 마커 검사 시장 - 브라질
    • 심장 마커 검사 시장 - 아르헨티나

제9장 경쟁 상황

  • 확장과 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers
  • Becton Dickson
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • LSI Medience
  • Quidel Corporation
  • Randox Laboratories
  • PerkinElmer
  • Tosoh Corporation
  • Alfa Scientific Designs
  • Response Biomedical
  • Creative Diagnostics
ksm 23.09.15

The global cardiac marker testing market size is expected to reach USD 9.73 billion by 2032, according to a new study by Polaris Market Research. The report "Cardiac Marker Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents and Kits and Instruments); By Biomarker Type; By End-User; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rapid increase in the number of cardiovascular disease patients globally in the emergency departments (EDs), the rising demand and adoption for several cardio biomarkers test like POCT, are prominent factors propelling the global market growth. Moreover, new players are continuously entering into the market with tests in order to generate maximum revenues and established players are focusing on developing and expanding their portfolio by investing in R&D activities, that are further anticipated to create growth opportunities. For instance, in January 2023, Cipla, introduced its new testing devices named 'Cippoint', a CE IVD-approved point-of-care testing device that offers testing for diabetes, infectious diseases, thyroid function, inflammation, and metabolic markers.

Moreover, the recent advances in the cardiac markers from the commercial devices to emerging technologies such as cardiac troponin and natriuretic peptides and Point-Of-Care immunoassays with improved specificity and reliability by enabling the multiplexing through the numerous molecular targets in single assays. The rising consumption of several types of unhealthy food products among millennials resulting in high number of angina pectoris cases, thus to cater the surging demand from these patient pool, adoption of cardiac biomarkers will increase rapidly.

With the drastic increase in the prevalence for cancer diseases and various other disorders and governments are heavily investing their time and money towards the development of their healthcare systems and access to advanced cardiac markers testing devices. For instance, according to a new study done by American College of Cardiology, researchers found that ApoB testing might help in the identification of patients who may still be at the high risk of cardiovascular without having normal LDL cholesterol levels.

Cardiac Marker Testing Market Report Highlights

Reagents and kits segment accounted for major global market share in 2022, on account on increasing adoption of the cardiac biomarker tests

Troponin I and T segment held the significant market revenue share in 2022, mainly due increasing demand for these devices to diagnose acute myocardial infraction

Point-of-care facilities segment is projected to grow at a highest CAGR over the study period, that is highly attributable to its growing utilization among major healthcare service providers

North America region dominated the global market in 2022, owing to high spending on healthcare infrastructure and quick adoption of advanced cardiac biomarkers in countries like US and Canada

The global key market players include: Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Medtronic PLC; Stryker Corporation; Zimmer-Biomet Holdings, Inc.; DePuy Synthes; Smith and Nephew PLC; Aesculap Implant Systems, LLC; Conmed Corporation; Donjoy, Inc.; NuVasive, Inc. and Roche

Polaris Market Research has segmented the cardiac marker testing market report based on product, biomarker type, end-user, and region:

Cardiac Marker Testing, Product Outlook (Revenue - USD Billion, 2018 - 2030)

  • Reagents and Kits
  • Instruments

Cardiac Marker Testing, Biomarker Type Outlook (Revenue - USD Billion, 2018 - 2030)

  • Troponin I and T
  • Creatine Kinase-MB (CK-MB)
  • Natriuretic Peptide
  • Myoglobin
  • High Sensitivity C-Reactive Protein
  • Other Cardiac Biomarkers

Cardiac Marker Testing, End-User Outlook (Revenue - USD Billion, 2018 - 2030)

  • Laboratory Testing Facilities
  • Point-Of-Care Testing Facilities
  • Academic Institutions

Cardiac Marker Testing, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cardiac Marker Testing Market Insights

  • 4.1. Cardiac Marker Testing Market - Biomarker Type Snapshot
  • 4.2. Cardiac Marker Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of cardiovascular diseases
      • 4.2.1.2. High technological advancements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Technical issues related to sample collection and storage
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cardiac Marker Testing Market Biomarker Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cardiac Marker Testing Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Reagents and Kits
    • 5.3.1. Global Cardiac Marker Testing Market, by Reagents and Kits, by Region, 2019-2032 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Cardiac Marker Testing Market, by Instruments, by Region, 2019-2032 (USD Billion)

6. Global Cardiac Marker Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Laboratory Testing Facilities
    • 6.3.1. Global Cardiac Marker Testing Market, by Laboratory Testing Facilities, by Region, 2019-2032 (USD Billion)
  • 6.4. Point-Of-Care Testing Facilities
    • 6.4.1. Global Cardiac Marker Testing Market, by Point-Of-Care Testing Facilities, by Region, 2019-2032 (USD Billion)
  • 6.5. Academic Institutions
    • 6.5.1. Global Cardiac Marker Testing Market, by Academic Institutions, by Region, 2019-2032 (USD Billion)

7. Global Cardiac Marker Testing Market, by Biomarker Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • 7.3. Troponin I and T
    • 7.3.1. Global Cardiac Marker Testing Market, by Troponin I and T, By Region, 2019-2032 (USD Billion)
  • 7.4. Creatine Kinase-MB (CK-MB)
    • 7.4.1. Global Cardiac Marker Testing Market, by Creatine Kinase-MB (CK-MB), By Region, 2019-2032 (USD Billion)
  • 7.5. Natriuretic Peptide
    • 7.5.1. Global Cardiac Marker Testing Market, by Natriuretic Peptide, By Region, 2019-2032 (USD Billion)
  • 7.6. Myoglobin
    • 7.6.1. Global Cardiac Marker Testing Market, by Myoglobin, By Region, 2019-2032 (USD Billion)
  • 7.7. High-Sensitivity C-Reactive Protein
    • 7.7.1. Global Cardiac Marker Testing Market, by High-Sensitivity C-Reactive Protein, By Region, 2019-2032 (USD Billion)
  • 7.8. Other Cardiac Biomarkers
    • 7.8.1. Global Cardiac Marker Testing Market, by Other Cardiac Biomarkers, By Region, 2019-2032 (USD Billion)

8. Global Cardiac Marker Testing Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cardiac Marker Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cardiac Marker Testing Market - North America
    • 8.3.1. North America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Cardiac Marker Testing Market - U.S.
      • 8.3.4.1. U.S.: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Cardiac Marker Testing Market - Canada
      • 8.3.5.1. Canada: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Cardiac Marker Testing Market - Europe
    • 8.4.1. Europe: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Cardiac Marker Testing Market - UK
      • 8.4.4.1. UK: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Cardiac Marker Testing Market - France
      • 8.4.5.1. France: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Cardiac Marker Testing Market - Germany
      • 8.4.6.1. Germany: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Cardiac Marker Testing Market - Italy
      • 8.4.7.1. Italy: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Cardiac Marker Testing Market - Spain
      • 8.4.8.1. Spain: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Cardiac Marker Testing Market - Netherlands
      • 8.4.9.1. Netherlands: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Cardiac Marker Testing Market - Russia
      • 8.4.10.1. Russia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Cardiac Marker Testing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Cardiac Marker Testing Market - China
      • 8.5.4.1. China: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Cardiac Marker Testing Market - India
      • 8.5.5.1. India: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Cardiac Marker Testing Market - Malaysia
      • 8.5.6.1. Malaysia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Cardiac Marker Testing Market - Japan
      • 8.5.7.1. Japan: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Cardiac Marker Testing Market - Indonesia
      • 8.5.8.1. Indonesia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Cardiac Marker Testing Market - South Korea
      • 8.5.9.1. South Korea: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Cardiac Marker Testing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Cardiac Marker Testing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Cardiac Marker Testing Market - UAE
      • 8.6.5.1. UAE: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Cardiac Marker Testing Market - Israel
      • 8.6.6.1. Israel: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Cardiac Marker Testing Market - South Africa
      • 8.6.7.1. South Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Cardiac Marker Testing Market - Latin America
    • 8.7.1. Latin America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Cardiac Marker Testing Market - Mexico
      • 8.7.4.1. Mexico: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Cardiac Marker Testing Market - Brazil
      • 8.7.5.1. Brazil: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Cardiac Marker Testing Market - Argentina
      • 8.7.6.1. Argentina: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. F. Hoffmann-La Roche AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Abbott Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Danaher Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Siemens Healthineers
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Becton Dickson
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Bio-Rad Laboratories
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Thermo Fisher Scientific
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. LSI Medience
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Quidel Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Randox Laboratories
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. PerkinElmer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Tosoh Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Alfa Scientific Designs
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Response Biomedical
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Creative Diagnostics
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제